Skip to content

Counseling on Injectable Contraception and HIV Risk in Tanzania

Counseling on Injectable Contraception and HIV Risk: Evaluation of a Pilot Intervention in Tanzania

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04160169
Enrollment
10
Registered
2019-11-12
Start date
2018-09-01
Completion date
2018-11-30
Last updated
2019-11-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contraception

Keywords

Counseling, Tanzania

Brief summary

The main objective of the evaluation was to assess the effect of providing injectable and HIV risk counseling messages on contraceptive knowledge and behavior during a three month pilot intervention in ten healthcare facilities in Tanzania.

Detailed description

The evaluation assessed the effect of providing injectable and HIV risk counseling messages on contraceptive knowledge and uptake during a three month pilot intervention. The intervention was conducted September-November 2018 in ten healthcare facilities located in the Iringa and Njombe regions of Tanzania. Data collection for the evaluation occurred November-December 2018 and included 471 client exit interviews, 26 healthcare provider interviews, and the extraction of monthly aggregate service statistics for 12 months prior to the intervention and three months of the intervention. Univariate and bivariate analyses were used to assess quantitative interview data. Thematic qualitative assessment was used to assess qualitative interview data from healthcare providers. Interrupted time series analysis was used to assess changes in the trend of monthly contraceptive uptake.

Interventions

OTHERCounseling messages on injectable use and HIV acquisition risk

Counseling messages based on 2017 World Health Organization guidance, a review of the Strategic Communication Framework for Hormonal Contraceptive Methods and Potential HIV-related Risks, and the Family Planning Global Handbook were provided to clients expressing interest in injectables during regular family planning appointments.

Sponsors

United States Agency for International Development (USAID)
CollaboratorFED
Ministry of Health, Tanzania
CollaboratorOTHER_GOV
Johns Hopkins Bloomberg School of Public Health
CollaboratorOTHER
University of North Carolina, Chapel Hill
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
15 Years to 49 Years

Inclusion criteria

* Expressed interest in injectable use * HIV-negative or unknown HIV status

Exclusion criteria

* Positive HIV status known to healthcare provider

Design outcomes

Primary

MeasureTime frameDescription
Number of clients obtaining an injectable during their family planning appointmentAfter implementation of counseling messages, up to 13 weeksInjectable uptake of interviewed clients
Percent of clients obtaining an injectable during their family planning appointmentAfter implementation of counseling messages, up to 13 weeksInjectable uptake of interviewed clients
Monthly total number of family planning clients by method obtainedSeptember 2017 through November 2018Contraceptive uptake during pilot intervention

Secondary

MeasureTime frameDescription
Percent of correct True/False statements on hormonal contraception and HIV (11 total)After implementation of counseling messages, up to 13 weeksKnowledge of hormonal contraception and HIV risk messages
Number of correct hormonal contraception and HIV risk counseling messages mentioned during spontaneous recallAfter implementation of counseling messages, up to 13 weeksKnowledge of hormonal contraception and HIV risk messages
Percent of interviewed clients reporting an intention to use condoms as a dual methodAfter implementation of counseling messages, up to 13 weeksIntention to use condoms as a dual method
Number of interviewed clients reporting an intention to use condoms as a dual methodAfter implementation of counseling messages, up to 13 weeksIntention to use condoms as a dual method
Percent of correct hormonal contraception and HIV risk counseling messages mentioned during spontaneous recallAfter implementation of counseling messages, up to 13 weeksKnowledge of hormonal contraception and HIV risk messages
Number of correct True/False statements on hormonal contraception and HIV (11 total)After implementation of counseling messages, up to 13 weeksKnowledge of hormonal contraception and HIV risk messages

Countries

Tanzania

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026